CRIS Current Research Information System

NALDI, MARINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.231
EU - Europa 4.251
AS - Asia 2.037
AF - Africa 248
SA - Sud America 21
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 6
Totale 11.807
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.187
GB - Regno Unito 1.052
IT - Italia 981
CN - Cina 613
VN - Vietnam 546
SE - Svezia 526
DE - Germania 508
SG - Singapore 386
IN - India 289
UA - Ucraina 248
FR - Francia 193
IE - Irlanda 176
RU - Federazione Russa 143
EE - Estonia 80
ZA - Sudafrica 79
CH - Svizzera 74
CI - Costa d'Avorio 68
TG - Togo 63
BG - Bulgaria 61
KR - Corea 38
IR - Iran 35
CA - Canada 34
JO - Giordania 33
BE - Belgio 31
FI - Finlandia 29
GR - Grecia 25
TR - Turchia 23
ES - Italia 20
SC - Seychelles 16
PT - Portogallo 15
HR - Croazia 14
NL - Olanda 14
AT - Austria 11
HK - Hong Kong 11
MX - Messico 10
NG - Nigeria 10
BR - Brasile 9
JP - Giappone 9
PL - Polonia 9
TH - Thailandia 9
TW - Taiwan 9
CL - Cile 8
DK - Danimarca 8
PK - Pakistan 8
AU - Australia 7
CZ - Repubblica Ceca 7
ID - Indonesia 7
RO - Romania 7
EU - Europa 6
NZ - Nuova Zelanda 5
SI - Slovenia 5
LB - Libano 4
LT - Lituania 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
BD - Bangladesh 3
EC - Ecuador 3
CM - Camerun 2
DZ - Algeria 2
IL - Israele 2
KZ - Kazakistan 2
MA - Marocco 2
NO - Norvegia 2
PH - Filippine 2
SM - San Marino 2
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
EG - Egitto 1
HU - Ungheria 1
IQ - Iraq 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MY - Malesia 1
NC - Nuova Caledonia 1
PY - Paraguay 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
UZ - Uzbekistan 1
Totale 11.807
Salva come PNG Salva come JPEG
Città #
Southend 948
Ashburn 766
Chandler 610
Fairfield 468
Dong Ket 374
Singapore 337
Bologna 303
Wilmington 252
Houston 243
Princeton 230
Woodbridge 225
Seattle 189
Cambridge 181
Dublin 176
Ann Arbor 171
Jacksonville 165
Westminster 99
Berlin 89
Nanjing 82
Padova 79
Abidjan 68
Lomé 63
Milan 63
Sofia 60
Medford 58
Bern 57
Jinan 55
Shenyang 55
Turin 55
Santa Clara 52
Hebei 46
Saint Petersburg 44
Beijing 43
Redmond 42
San Diego 42
Falls Church 40
New York 37
Redwood City 36
Boardman 34
Amman 33
Changsha 33
Brussels 30
Des Moines 29
Mülheim 29
Nanchang 27
Bremen 25
Dearborn 25
Tianjin 24
Guangzhou 22
Jiaxing 20
Helsinki 19
Paris 19
Ottawa 18
Los Angeles 17
Mahé 16
Hangzhou 15
Hyderabad 14
Norwalk 14
Fremont 13
Verona 13
Haikou 12
Olalla 12
Rome 12
Zhengzhou 12
Taiyuan 11
Taizhou 11
Thessaloniki 11
Amsterdam 10
Istanbul 10
Lappeenranta 10
London 10
Pune 10
Shanghai 10
Abeokuta 9
Cesena 9
Chicago 9
Forlì 9
San Jose 9
San Venanzo 9
Florence 8
Frankfurt Am Main 8
Hong Kong 8
Kunming 8
Lisbon 8
New Haven 8
Ravenna 8
Toronto 8
Vienna 8
Washington 8
Casalecchio di Reno 7
Costa Mesa 7
Lausanne 7
Mountain View 7
Mumbai 7
Seoul 7
Chennai 6
Fuzhou 6
Lanzhou 6
Madrid 6
Nagold 6
Totale 7.739
Salva come PNG Salva come JPEG
Nome #
Mechanism and stereoselectivity of HDAC I inhibition by (R)-9-hydroxystearic acid in colon cancer. 462
STABILITY OF ASCORBIC ACID IN COSMETIC FORMULATION: PROTECTIVE ROLE OF RESVERATROL AND MELATONIN 236
Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatment 216
Advanced analytical methodologies in Alzheimer's disease drug discovery 213
Albumin homodimers in patients with cirrhosis: clinical and prognostic relevance of a novel identified structural alteration of the molecule. 175
Characterisation of the conjugate of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin with lactosaminated human albumin by 13C NMR spectroscopy. 168
Antitumoral Efficacy of Two Turmeric Extracts According to Different Extraction Methods in Hepatocellular Carcinoma Cell Lines 153
Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo 151
Structural basis for the magnesium-dependent activation of transketolase from Chlamydomonas reinhardtii 147
Antioxidant and cytoprotective effects of a wheat-derived non specific lipid transfer protein 2 (nsLTP2) on vascular endothelial cells 145
A fast and validated mass spectrometry method for the evalutation of human serum albumin structural modifications in the clinical field. 143
AFM study of F-actin on chemically modified surfaces 142
Analysis of human histone H4 by capillary electrophoresis in a pullulan-coated capillary, LC-ESI-MS and MALDI-TOF-MS 142
Exploiting the chalcone scaffold to develop multifunctional agents for Alzheimer’s disease 142
Indole derivative interacts with estrogen receptor beta and inhibits human ovarian cancer cell growth 141
ON-LINE GLYCAN RELEASE AND ANALYSIS BY AN INTEGRATED PNGASE F-IMER LC-ESI-Q-TOF APPROACH 137
Synthesis, cytotoxicity and anti-cancer activity of new alkynyl-gold(I) complexes 136
ANTIPROLIFERATIVE ACTIVITY OF ENANTIOMERICALLY PURE (R) AND (S)-9-HYDROXYSTEARIC ACID IN HT29 COLON CANCER CELLS. 135
null 135
Mass spectrometry characterization of circulating human serum albumin microheterogeneity in patients with alcoholic hepatitis. 133
AFM study of F-actin on chemically modified surfaces 131
HS-SPME-GC-MS for the quantitation and chiral characterization of camphor and menthol in creams 129
9-HSA INDUCES APOPTOSIS AND INCREASES SENSITIVITY TO IMATINIB IN IMATINIB RESISTANT COLON CANCER CELLS 128
A MULTI-METHODOLOGICAL APPROACH FOR BETA-AMYLOID AGGREGATION AND INHIBITION STUDIES 127
Immobilized Enzyme Reactors: an Overview of Applications in Drug Discovery from 2008 to 2018 127
Discovery of sustainable drugs for Alzheimer's disease: cardanol-derived cholinesterase inhibitors with antioxidant and anti-amyloid properties 127
9-Hydroxystearic acid and sulforaphane: two natural HDAC inhibitors with distinct effects on HT29 cells. 124
Acetylcholinesterase oriented immobilization on nanopatterned bilayered surfaces for biosensing devices 122
Amyloid beta-Peptide 25-35 Self Assembly and Its Inhibition: A Model Undecapeptide System to Gain Atomistic and Secondary Structure Details of the Alzheimer's Disease Process and Treatment 122
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications 121
Isolation and Characterization of Wheat Derived Nonspecific Lipid Transfer Protein 2 (nsLTP2) 120
New insights into the altered binding capacity of pharmaceutical-grade human serum albumin: site-specific binding studies by induced circular dichroism spectroscopy 120
Analytical approaches in Alzheimer’s disease Drug Discovery 117
Rapid MALDI-TOF-MS analysis in the study of interaction between whole bacterial cells and human target molecules: binding of Bifidobacterium to human plasminogen 116
ALZHEIMER'S DISEASE DRUG DISCOVERY: NEW ANALYTICAL APPROACHES FOR LEAD SELECTION AND OPTIMIZATION PBA 2009 (20h International Symposium on Pharmaceutical and Biomedical Analysis), Agra, India 01-04 Marzo 2009 115
AMYLOID-b-PEPTIDE SELF ASSEMBLY KINETICS BY AFM AND MALDI-TOF MASS SPECTROMETRY 114
Mass spectrometric characterization of human serum albumin dimer: A new potential biomarker in chronic liver diseases. 114
Simple and rapid LC-MS method for the determination of circulating albumin microheterogeneity in veal calves exposed to heat stress 114
Headspace solid-phase microextraction gas chromatography-mass spectrometry (HS SPME-GC-MS) determination of odorants in green tea 112
Posttranscriptional changes of serum albumin: clinical and prognostic meaning in hospitalized patients with cirrhosis. 111
Unveiling the Biochemistry of the Epigenetic Regulator SMYD3 111
CE Analysis of Basic Proteins and H4 Human Histones using a Pullulan-Coated Capillary 109
Cell cycle arrest induced by sulforaphane in human colon carcinoma cells HT29 is associated with the hyperacetylation of histone H4. 108
IMMOBILIZED ENZYMES AS TOOLS IN DRUG DISCOVERY 106
Development and characterization of beta-secretase monolithic micro-immobilized enzyme reactor for on-line high-performance liquid chromatography studies 105
Immobilized enzyme-based analytical tools in the -omics era: recent advances 104
In vitro thrombogenicity of drug-eluting and bare metal stents 104
BIOLOGICAL EFFECTS OF A NEW CLASS I HDAC SELECTIVE INHIBITOR IN HT29 COLON CANCER CELLS. 103
UHPLC determination of catechins for the quality control of green tea 102
Fluorescence biosensing micropatterned surfaces based on immobilized human acetylcholinesterase 102
ANALYTICAL STRATEGIES FOR THE CHARACTERIZATION OF PROTEIN AGGREGATION AND INHIBITION IN HUMAN DISEASES 100
HEADSPACE SOLID-PHASE MICROEXTRACTION GAS CHROMATOGRAPHY-MASS SPECTROMETRY (HS SPME-GC-MS) DETERMINATION OF ODORANTS IN GREEN TEA 100
Structural characterization of p53 isoforms due to the polymorphism at codon 72 by Mass Spectrometry and Circular Dichroism. 100
null 99
A patent review of butyrylcholinesterase inhibitors and reactivators 2010–2017 97
Ischemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis. 96
Histone proteins determined in a human colon cancer by high-performance liquid chromatography and mass spectrometry 95
- Application of an ESI-MS method enabling the discovery of new non-ATP competitive GSK-3beta inhibitors. 95
Towards automation in protein digestion: Development of a monolithic trypsin immobilized reactor for highly efficient on-line digestion and analysis 95
Kinetic characterization of amyloid-beta 1-42 aggregation with a multimethodological approach. 94
New Coumarin derivatives as cholinergic and cannabinoid system modulators 93
null 92
Multiwell fluorometric and colorimetric microassays for the evaluation of beta-secretase (BACE-1) inhibitors. 91
ACETYLCHOLINESTERASE-BASED ANALYTICAL TOOLS FOR DRUG SCREENING 90
Application of an ESI-MS method enabling the discovery of new non-ATP competitive GSK-3beta inhibitors. 90
Application of ESI-MS method for detailed characterization of GSK-3β inhibitors by monitoring GSM peptide phosphorylation.Angelini Farmaceutici. 89
Histone post-translational modifications by HPLC-ESI-MS after HT29 cell treatment with histone deacetylase inhibitors 89
HISTONE POST-TRANSLATIONAL MODIFICATIONS BY HPLC-ESI-MS AFTER HT29 CELL TREATMENT WITH HDACS INHIBITORS. 88
Investigating in vitro amyloid peptide 1−42 aggregation: Impact of higher molecular weight stable adducts 87
Development of Beta-secretase monolithic micro-imer (immobilized enzyme reactor) for on-line HPLC studies 86
IDENTIFICATION OF HISTONE MODIFICATIONS INVOLVED IN HDACs INHIBITION BY SUBEROYLANILIDE HYDROXAMIC ACID. 85
Redox-sensitive structural features of transketolase from Chlamydomonas reinhardtii (CrTK) 85
Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer's disease: Selective subnanomolar BuChE inhibitors 85
IDENTIFICATION OF HISTONE MODIFICATIONS INVOLVED IN HDAC1 INHIBITION BY 9-HSA 82
HPLC determination of β-secretase activity on monolithic CIM disks 82
EPITOPE IDENTIFICATION OF GLYCATED HSA AND THE EXTRACELLULAR REGION OF HUMAN RAGE BY SPR AND AFFINITY-MS SPECTROMETRY 81
Climate change effects on bread wheat phenology and grain quality: A case study in the north of Italy 80
Polycyclic Maleimide-based Scaffold as New Privileged Structure for Navigating the Cannabinoid System Opportunities 80
Discovery of an Allosteric Ligand Binding Site in SMYD3 Lysine Methyltransferase 80
From combinations to single-molecule polypharmacology—cromolyn-ibuprofen conjugates for alzheimer’s disease 80
The role of Chromatography in Alzheimer’s Disease Drug Discovery. 79
null 79
HISTONE POST-TRANSLATIONAL MODIFICATIONS DETERMINED BY HIGH-PRESSURE LIQUID CHROMATOGRAPHY AND MASS SPECTROMETRY 78
Hystones’ isoforms determined by HPLC-MS 78
Peptide mass mapping of acetylated isoforms of histone H4 from HT29 colon cancer cells 78
UHPLC ANALYSIS OF CATECHINS IN GREEN TEAS 78
PROTEIN GLYCOSILATION ANALYSIS BY AN INTEGRATED PNGASE-F-IMER-LC-ESI-Q-TOF APPROACH 78
Histones post-translational modifications in colon cancer cell line determined by HPLC-ESI-MS and Maldi-Tof for the characterization of deacetylase inhibitors 77
null 77
The cell cycle arrest induced by sulforaphane in human colon carcinoma cells HT29 is associated with the hyperacetylation of histone H4. 76
Development of beta-secretase monolithic micro-IMER: characterization, activity and inhibition studies 73
Evidence of class I HDACs inhibition and cell cycle block in human carcinoma cells after (R) or (S)-9- HSA treatment 73
GA‐RAGE – Effetti dell’albumina glicata plasmatica sulla stimolazione di RAGE nel diabete mellito di tipo 2 con complicanze renali 73
null 72
Mass Spectrometry as efficient tool for the characterization of amyloid peptide 25-35 self-assembly species in aggregation and inhibition studies 71
β-Amyloid-CORMs interaction monitoring by LC-ESI/MS and Circular Dichroism studies 69
New analytical tools to investigate the role of protein glycosylation in Alzheimer’s disease 67
A multi-methodological approach for the investigation of β-Amyloid-CORMs interaction: an LC-ESI/MS and Circular Dichroism study. 67
Functional characterization of multifunctional ligands targeting acetylcholinesterase and alpha 7 nicotinic acetylcholine receptor 66
PROTEOMIC ANALYSIS OF POST-TRANSLATIONAL MODIFICATIONS OF HUMAN HISTONES IN CANCER DRUG DISCOVERY 65
Totale 11.077
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.313
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.313
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.902 0 0 56 142 188 208 246 338 277 186 117 144
2020/20211.774 317 119 42 72 47 68 71 125 155 89 99 570
2021/20222.278 257 85 93 124 213 128 67 198 114 177 422 400
2022/20232.561 225 315 157 330 195 210 61 186 398 110 190 184
2023/20241.340 59 125 66 86 72 154 235 307 43 67 95 31
2024/2025795 148 435 212 0 0 0 0 0 0 0 0 0
Totale 12.177